IAIM
GMAB icon

International Assets Investment Management’s Genmab GMAB Stock Holding History

International Assets Investment Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,410
Closed -$427 – 1217
2024
Q3 		$427 Buy
+10,410
New +$278K ﹤0.01% 1382
2021
Q2 		– Sell
-210
Closed -$9K – 1030
2021
Q1 		$9K Hold
210
– – ﹤0.01% 1593
2020
Q4 		$9K Buy
+210
New +$7.85K ﹤0.01% 1462

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

International Assets Investment Management's GMAB Position: Q4 2024 in Review

International Assets Investment Management sold out of Genmab (GMAB) in Q4 2024, closing a stake of 10,410 shares — an estimated $427 sold.

International Assets Investment Management first reported a position in GMAB in Q4 2020 and held it in 3 quarters. The position peaked at $9K in Q1 2021. 229 funds tracked by Wall St. Rank hold GMAB as of Q4 2024.

  • International Assets Investment Management reported no remaining Genmab position as of Q4 2024 after selling out during the quarter.
  • International Assets Investment Management sold 10,410 Genmab shares in Q4 2024, an estimated $427.
  • International Assets Investment Management first reported a position in Genmab in Q4 2020 and held it in 3 quarters.
  • International Assets Investment Management's Genmab position peaked at $9K in Q1 2021.
  • 229 funds tracked by Wall St. Rank held Genmab as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.